Cargando…
The frequency of T regulatory cells modulates the survival of multiple myeloma patients: detailed characterisation of immune status in multiple myeloma
BACKGROUND: Multiple myeloma (MM) is an immunoproliferative disease characterised by the uncontrolled proliferation of plasma cells, which is accompanied by defects in the immune system. METHODS: This study aimed to characterise the frequency of T regulatory cells (Tregs), dendritic cells (DCs) as w...
Autores principales: | Giannopoulos, K, Kaminska, W, Hus, I, Dmoszynska, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3273338/ https://www.ncbi.nlm.nih.gov/pubmed/22223085 http://dx.doi.org/10.1038/bjc.2011.575 |
Ejemplares similares
-
Active multiple myeloma suppresses and typically eliminates coexisting MGUS
por: Campbell, John P, et al.
Publicado: (2017) -
PDK1 inhibition is a novel therapeutic target in multiple myeloma
por: Fujiwara, S, et al.
Publicado: (2013) -
Identification of circulating microRNAs as diagnostic biomarkers for use in multiple myeloma
por: Jones, C I, et al.
Publicado: (2012) -
High level of interleukin-10 in serum predicts poor prognosis in multiple myeloma
por: Wang, Hua, et al.
Publicado: (2016) -
Tetraspanin-induced death of myeloma cell lines is autophagic and involves increased UPR signalling
por: Zismanov, V, et al.
Publicado: (2009)